GSK Q3FY25 Results: Profit Grows Four Times to ₹229 Crore
On February 14, GlaxoSmithKline Pharmaceuticals Ltd. reported an 18% rise in sales to ₹946 crore for the 3 quarter that ended on December 31, 2024, with a profit after tax of ₹229 crore. GSK Q3FY25 Results: Today, February 14, GlaxoSmithKline Pharmaceuticals Ltd. (GSK) reported its third-quarter financial results, which concluded on December 31, 2024. The […]
GSK Q3FY25 Results: Profit Grows Four Times to ₹229 Crore Read More »